Finance

Lists
Why is FAB down 3,67%?
Dive Deeper
FAB:LON
Fusion Antibodies PLC
9,63 GBX
-3,67%
(-0,37) 1D
12-окт., 15:46:02 GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for FAB...
Open
10,50 GBX
High
10,50 GBX
Low
9,50 GBX
Mkt. cap
12,06 млн
Avg. vol.
398,64 миң
Volume
78,12 миң
52-wk high
20,00 GBX
52-wk low
9,00 GBX
EPS
-0,01 GBX
Shares outstanding
125,16 млн
No. of employees
27
Open
10,50 GBX
High
10,50 GBX
Low
9,50 GBX
Mkt. cap
12,06 млн
Avg. vol.
398,64 миң
Volume
78,12 миң
52-wk high
20,00 GBX
52-wk low
9,00 GBX
EPS
-0,01 GBX
Shares outstanding
125,16 млн
No. of employees
27
News stories
From web sources and news partners
bloomingbit
bloomingbit
·
46 мүнөт мурун
XRP Treasury Firm Evernode Gains 5% in Nasdaq Debut
HME News
HME News
·
43 мүнөт мурун
Accendra Health on notice from NYSE
About Fusion Antibodies PLC
CEO-
Employees27
Founded2000
Headquarters-
SectorHealth care
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
419,00 миң
419,00 миң
636,00 миң
636,00 миң
Cost of goods sold
295,50 миң
295,50 миң
144,00 миң
144,00 миң
Cost of revenue
295,50 миң
295,50 миң
144,00 миң
144,00 миң
Research and development expenses
175,50 миң
175,50 миң
-175,50 миң
-175,50 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
403,00 миң
403,00 миң
1,14 млн
1,14 млн
Operating expense
393,50 миң
393,50 миң
776,50 миң
776,50 миң
Total operating expenses
689,00 миң
689,00 миң
920,50 миң
920,50 миң
Operating income
-270,00 миң
-270,00 миң
-284,50 миң
-284,50 миң
Other non operating income
-
-
-
-
EBT including unusual items
-274,00 миң
-274,00 миң
-300,50 миң
-300,50 миң
EBT excluding unusual items
-274,00 миң
-274,00 миң
-300,50 миң
-300,50 миң
Income tax expense
-18,00 миң
-18,00 миң
18,00 миң
18,00 миң
Effective tax rate
6,57%
6,57%
-5,99%
-5,99%
Other operating expenses
-185,00 миң
-185,00 миң
-251,00 миң
-251,00 миң
Net income
-256,00 миң
-256,00 миң
-318,50 миң
-318,50 миң
Net profit margin
-61,10%
-61,10%
-50,08%
-50,08%
Earnings per share
-
-
-
-
Interest and investment income
1,00 миң
1,00 миң
1,00 миң
1,00 миң
Interest expense
-5,00 миң
-5,00 миң
-5,00 миң
-5,00 миң
Net interest expenses
-4,00 миң
-4,00 миң
-4,00 миң
-4,00 миң
Depreciation and amortization charges
-
-
63,50 миң
63,50 миң
EBITDA
-254,00 миң
-254,00 миң
-274,50 миң
-274,50 миң
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору